Everything You Need to Know from the American College of Cardiology 2025 Scientific Session
Season 1 Episode 2 · Apr 01, 2025, 04:14 PM
Share
Subscribe
This episode discussed multiple studies. See the list below for links to articles and relevant content:
REVERSE-IT trial data:
REVERSE-IT trial data:
- https://www.pharmacytimes.com/view/acc-2025-ticagrelor-antidote-restores-platelet-function-treats-bleeding
- https://evidence.nejm.org/doi/full/10.1056/EVIDoa210004
FAIR-HF2 trial data:
- https://www.pharmacytimes.com/view/acc-2025-intravenous-iron-safe-but-results-in-mixed-findings-for-patients-with-heart-failure
- https://jamanetwork.com/journals/jama/fullarticle/2832132
STRIDE trial data:
- https://www.pharmacytimes.com/view/acc-2025-semaglutide-significantly-improves-walking-distance-symptoms-qol-for-individuals-with-pad-and-diabetes
- https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00509-4/abstract
ADVANCE-HTN trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/15/49/advance-htn
FRESH-UP trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/17/26/fresh-up
FINEARTS-HF trial: https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2025/03/05/17/27/FINEARTS-HF-Analysis
FRESH-UP trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/17/26/fresh-up
FINEARTS-HF trial: https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2025/03/05/17/27/FINEARTS-HF-Analysis